Search results for " observations"

showing 10 items of 100 documents

Modeling Atmospheric Turbulence via Rapid Distortion Theory: Spectral Tensor of Velocity and Buoyancy

2017

Abstract A spectral tensor model is presented for turbulent fluctuations of wind velocity components and temperature, assuming uniform vertical gradients in mean temperature and mean wind speed. The model is built upon rapid distortion theory (RDT) following studies by Mann and by Hanazaki and Hunt, using the eddy lifetime parameterization of Mann to make the model stationary. The buoyant spectral tensor model is driven via five parameters: the viscous dissipation rate ε, length scale of energy-containing eddies L, a turbulence anisotropy parameter , gradient Richardson number (Ri) representing the local atmospheric stability, and the rate of destruction of temperature variance . Model outp…

Length scaleAtmospheric Science010504 meteorology & atmospheric sciencesK-epsilon turbulence modelFLOWVelocityTensorsWind01 natural sciencesWind speedAtmospheric temperature010305 fluids & plasmasPhysics::Fluid DynamicsEnergy-containing eddiesConvergence of numerical methodsMonin-Obukhov similarity theorySCALEPhysicsTurbulenceAtmospheric turbulenceMechanicsBuoyancySURFACE-LAYER TURBULENCEClassical mechanicsFluxesStratified turbulenceSIMILARITYSIMULATIONBoundary layersStabilityBuoyancyMETEOROLOGYengineering.materialPROFILEAtmospheric thermodynamics0103 physical sciencesAtmospheric instabilityWind shearsSTABLY STRATIFIED TURBULENCETensorRapid distortion theory0105 earth and related environmental sciencesWind shearBoundary layer flowRichardson numberAtmospheric observationsViscous dissipation rateHorizontal array turbulence study field programsTurbulenceBoundary layerengineeringJournal of the Atmospheric Sciences
researchProduct

Multimessenger search for sources of gravitational waves and high-energy neutrinos: Initial results for LIGO-Virgo and IceCube

2014

Made available in DSpace on 2022-04-29T07:21:49Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-11-17 We report the results of a multimessenger search for coincident signals from the LIGO and Virgo gravitational-wave observatories and the partially completed IceCube high-energy neutrino detector, including periods of joint operation between 2007-2010. These include parts of the 2005-2007 run and the 2009-2010 run for LIGO-Virgo, and IceCube's observation periods with 22, 59 and 79 strings. We find no significant coincident events, and use the search results to derive upper limits on the rate of joint sources for a range of source emission parameters. For the optimistic assumption of …

MECHANISMPhysics and Astronomy (miscellaneous)AstrophysicsFOLLOW-UP OBSERVATIONSASTROPHYSICAL SOURCESIceCubeneutrinoDetection of gravitational waveGravitational waves neutrinoObservatory[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]QCLIGO Scientific CollaborationQBPhysicsGAMMA-RAY BURSTS[SDU.ASTR.HE]Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Settore FIS/01 - Fisica SperimentaleAstrophysics::Instrumentation and Methods for AstrophysicsASTRONOMYNuclear and High Energy Physics; Physics and Astronomy (miscellaneous)NEUTRINOSNeutrino detectorComputingMethodologies_DOCUMENTANDTEXTPROCESSINGNeutrinoSENSITIVITYGIANT FLARENuclear and High Energy Physics[PHYS.ASTR.HE]Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]95.85.RyMUON NEUTRINOSAstrophysics::High Energy Astrophysical PhenomenaAstrophysics::Cosmology and Extragalactic AstrophysicsACCELERATIONGravitational wavesGeneral Relativity and Quantum CosmologyINSTABILITIESSettore FIS/05 - Astronomia e AstrofisicaCORE-COLLAPSE SUPERNOVAE[ PHYS.HEXP ] Physics [physics]/High Energy Physics - Experiment [hep-ex]ddc:530SDG 7 - Affordable and Clean EnergyCORE-COLLAPSEDETECTOR/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyGravitational wave95.85.SzMAGNETIZED NEUTRON-STARS[ PHYS.ASTR.HE ] Physics [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]AstronomyTRANSIENTS95.85.Sz; 95.85.RyRELATIVISTIC STARSLIGOPhysics and Astronomy[ SDU.ASTR.HE ] Sciences of the Universe [physics]/Astrophysics [astro-ph]/High Energy Astrophysical Phenomena [astro-ph.HE]Gamma-ray burstEMISSIONEnergy (signal processing)
researchProduct

Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

2021

Abstract Tisagenlecleucel (tisa‐cel) is a second‐generation autologous CD19‐targeted chimeric antigen receptor (CAR) T‐cell therapy approved for relapsed/refractory (R/R) large B‐cell lymphoma (LBCL). The approval was based on the results of phase II JULIET trial, with a best overall response rate (ORR) and complete response (CR) rate in infused patients of 52% and 40%, respectively. We report outcomes with tisa‐cel in the standard‐of‐care (SOC) setting for R/R LBCL. Data from all patients with R/R LBCL who underwent leukapheresis from December 2018 until June 2020 with the intent to receive SOC tisa‐cel were retrospectively collected at 10 Spanish institutions. Toxicities were graded accor…

Male0301 basic medicine:aminoácidos péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores inmunológicos::receptores de antígenos::receptores de antígenos de linfocitos T [COMPUESTOS QUÍMICOS Y DROGAS]Cancer Researchnon‐Hodgkin's lymphomaBest Overall Responsehematological cancer:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Non- Hodgkin's lymphomaGastroenterology0302 clinical medicineMedicine research:Other subheadings::/therapeutic use [Other subheadings]CàncerB-cell lymphomaRC254-282CancerOriginal ResearchReceptors Chimeric AntigenNeoplasms. Tumors. Oncology. Including cancer and carcinogensnon&#8208Standard of CareMiddle AgedPatologiaHodgkin&aposProgression-Free SurvivalCytokine release syndromeclinical cancer researchOncology:neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso [ENFERMEDADES]030220 oncology & carcinogenesisCytokinesFemaleLymphoma Large B-Cell Diffusenon-Hodgkin's lymphomamedicine.medical_specialtyReceptors Antigen T-CellCèl·lules B - Tumors - Tractament:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Investigació mèdicaReal world evidence03 medical and health sciencess lymphoma:Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma Non-Hodgkin::Lymphoma B-Cell::Lymphoma Large B-Cell Diffuse [DISEASES]Refractoryclinical observationsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingLeukapheresis:Amino Acids Peptides and Proteins::Proteins::Membrane Proteins::Receptors Cell Surface::Receptors Immunologic::Receptors Antigen::Receptors Antigen T-Cell [CHEMICALS AND DRUGS]AgedRetrospective Studies:Otros calificadores::/uso terapéutico [Otros calificadores]business.industryTeràpia cel·lularClinical Cancer ResearchLeukapheresismedicine.diseaseMalaltia de HodgkinNon-Hodgkin's lymphomaLymphoma030104 developmental biologyHodgkin's diseaseNeoplasm Recurrence LocalbusinessCancer Medicine
researchProduct

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

2014

Atypical hemolytic-uremic syndrome (aHUS) is associated with genetic complement abnormalities/anti–complement factor H antibodies, which paved the way to treatment with eculizumab. We studied 44 aHUS patients and their relatives to (1) test new assays of complement activation, (2) verify whether such abnormality occurs also in unaffected mutation carriers, and (3) search for a tool for eculizumab titration. An abnormal circulating complement profile (low C3, high C5a, or SC5b-9) was found in 47% to 64% of patients, irrespective of disease phase. Acute aHUS serum, but not serum from remission, caused wider C3 and C5b-9 deposits than control serum on unstimulated human microvascular endotheli…

MaleTime FactorsClinical Trials and ObservationsComplement Membrane Attack Complexurologic and male genital diseasesBiochemistryGlomerulonephritisInside BLOOD Commentaryhemic and lymphatic diseasesMembranoproliferative glomerulonephritisMonoclonalHumanizedComplement ActivationAtypical Hemolytic Uremic SyndromeEndothelial CellHematologyRemission Inductionfood and beveragesHematologyComplement C3Eculizumabmedicine.anatomical_structureFactor HFemalecomplementaHUS eculizumabmedicine.drugMembranoproliferativeHumanmedicine.medical_specialtyEndotheliumMonitoringTime FactorGlomerulonephritis MembranoproliferativeImmunologyBiologyAntibodies Monoclonal HumanizedAntibodiesInternal medicineAtypical hemolytic uremic syndromemedicineHumansPhysiologicMonitoring PhysiologicAdenosine Diphosphate RiboseEndothelial CellsCell Biologymedicine.diseaseComplement systemImmunologyAdenosine Diphosphate Ribose; Antibodies Monoclonal Humanized; Atypical Hemolytic Uremic Syndrome; Complement Activation; Complement C3; Complement Membrane Attack Complex; Endothelial Cells; Female; Glomerulonephritis Membranoproliferative; Hemolytic-Uremic Syndrome; Humans; Male; Remission Induction; Time Factors; Monitoring Physiologic; Hematology; Biochemistry; Cell Biology; ImmunologyHemolytic-Uremic SyndromeComplement membrane attack complexBlood
researchProduct

Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia

2011

We conducted an international phase 2 trial to evaluate 2 dose levels of ofatumumab, a human CD20 mAb, combined with fludarabine and cyclophosphamide (O-FC) as frontline therapy for chronic lymphocytic leukemia (CLL). Patients with active CLL were randomized to ofatumumab 500 mg (n = 31) or 1000 mg (n = 30) day 1, with fludarabine 25 mg/m2 and cyclophosphamide 250 mg/m2 days 2-4, course 1; days 1-3, courses 2-6; every 4 weeks for 6 courses. The first ofatumumab dose was 300 mg for both cohorts. The median age was 56 years; 13% of patients had a 17p deletion; 64% had β2-microglobulin > 3.5 mg/L. Based on the 1996 National Cancer Institute Working Group (NCI-WG) guidelines, the complete respo…

Malemedicine.medical_specialtyCyclophosphamideClinical Trials and ObservationsChronic lymphocytic leukemiaImmunologyMedizinNeutropeniaOfatumumabAntibodies Monoclonal HumanizedBiochemistryGastroenterologychemistry.chemical_compoundChemoimmunotherapyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansCyclophosphamideCD20Chlorambucilbiologybusiness.industryAntibodies MonoclonalCell BiologyHematologyMiddle Agedmedicine.diseaseCombined Modality TherapyLeukemia Lymphocytic Chronic B-CellNeoadjuvant TherapySurgeryFludarabineTreatment Outcomechemistrybiology.proteinFemaleImmunotherapybusinessVidarabinemedicine.drug
researchProduct

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Tri…

2021

This article belongs to the Collection The Biomarkers for the Diagnosis and Prognosis in Cancer.

Neuroblastoma RAS viral oncogene homologOncologyCancer Researchgenetic riskMyeloid neoplasialeukemic cells0302 clinical medicinecytarabineclinical trials and observations:Other subheadings::/diagnosis [Other subheadings]MedicineComplete remissionazacytidineolder adultsRC254-282variantsLeukemiaAzacytidineHazard ratioleukemiaVariantsCytarabineacute:Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia Myeloid::Leukemia Myeloid Acute [DISEASES]Neoplasms. Tumors. Oncology. Including cancer and carcinogensMyeloid leukemiaFludarabineLeukemiaOncology030220 oncology & carcinogenesisNGSOlder adultsLeucèmia mieloide aguda - Tractamentmyeloid neoplasiaMyelocyticmedicine.drugmedicine.medical_specialtymyelocyticcomplete remission:Otros calificadores::/diagnóstico [Otros calificadores]Subgroup analysisLeukemic cellsAcutePrognostic factorsArticle:neoplasias::neoplasias por tipo histológico::leucemia::leucemia mieloide::leucemia mieloide aguda [ENFERMEDADES]03 medical and health sciencesInternal medicineGenetic riskbusiness.industryprognostic factors:diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]Odds ratio:Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]medicine.diseaseAvaluació de resultats (Assistència sanitària)CytarabinebusinessClinical trials and observations030215 immunology
researchProduct

The Flipped Classroom: a Way to Decrease Boredom and Encourage Student Motivation. La classe capovolta: un modo per diminuire la noia ed incoraggiare…

2016

Recenti studi hanno mostrato l'effetto della noia sul successo. L'esperienza della noia vissuta da molti studenti, insieme con i suoi effetti deleteri, implica chiaramente che educatori ed insegnanti, in quanto responsabili della progettazione di ambienti di apprendimento, prestino maggiore attenzione a questa emozione. Questo contributo intende esaminare l'impatto del modello di insegnamento capovolto sul processo di apprendimento dello studente. Nella ricerca sono state utilizzate differenti metodologie, tra cui un inventario sulla percezione degli studenti e l'osservazione delle pratiche di insegnamento, per indagare se ed in che modo gli insegnanti riescono a gestire la noia in modo div…

Noia classe capovolta osservazione delle pratiche di insegnamento autoregolazioneBoredom Flipped Observations of Teacher Practices Self-RegulationSettore M-PED/04 - Pedagogia Sperimentale
researchProduct

Search for gamma ray bursts with the ARGO-YBJ detector in scaler mode

2009

We report on the search for Gamma Ray Bursts (GRBs) in the energy range 1-100 GeV in coincidence with the prompt emission detected by satellites using the Astrophysical Radiation with Ground-based Observatory at YangBaJing (ARGO-YBJ) air shower detector. Thanks to its mountain location (Yangbajing, Tibet, P.R. China, 4300 m a.s.l.), active surface (about 6700 m**2 of Resistive Plate Chambers), and large field of view (about 2 sr, limited only by the atmospheric absorption), the ARGO-YBJ air shower detector is particularly suitable for the detection of unpredictable and short duration events such as GRBs. The search is carried out using the "single particle technique", i.e. counting all the …

Nuclear and High Energy PhysicsGamma ray burstAstrophysics::High Energy Astrophysical PhenomenaAir shower arrayAstrophysicsArgo-YbjSettore FIS/05 - Astronomia e AstrofisicaObservatoryGamma Rays ObservationsInstrumentationZenithArgoPhysicsRange (particle radiation)Apparati di sciameDetectorSettore FIS/01 - Fisica SperimentaleGamma rayGamma ray bursts Air shower arraysMode (statistics)Astrophysics::Instrumentation and Methods for AstrophysicsAstronomy and AstrophysicsRedshiftAir showerSpace and Planetary ScienceGamma Ray Bursts Gamma Ray EmissionAstrophysics - High Energy Astrophysical PhenomenaGamma-ray burst
researchProduct

SUSY-GUTs, SUSY-Seesaw and the Neutralino Dark Matter

2007

19 pages, 7 figures.-- ISI Article Identifier: 000249788800048.-- ArXiv pre-print available at: http://arxiv.org/abs/0704.3518

Nuclear and High Energy PhysicsParticle physicsDark matterFOS: Physical sciencesAstrophysics01 natural sciencesUpper and lower bounds[PHYS.ASTR.CO]Physics [physics]/Astrophysics [astro-ph]/Cosmology and Extra-Galactic Astrophysics [astro-ph.CO]High Energy Physics - Phenomenology (hep-ph)Seesaw molecular geometry0103 physical sciencesGUTFlavor violation010306 general physicsPhysics[PHYS]Physics [physics]Relic density010308 nuclear & particles physicsAstrophysics (astro-ph)Yukawa potentialSupersymmetryCMB cold spotSupersymmetry phenomenologyHigh Energy Physics - PhenomenologyProbe WMAP observations[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]NeutralinoStau coannihilationNeutrinoMSSM
researchProduct

Updated CMB and x- and gamma-ray constraints on Majoron dark matter

2013

The Majoron provides an attractive dark matter candidate, directly associated with the mechanism responsible for spontaneous neutrino mass generation within the standard model SU(3)(c) circle times SU(2)(L) circle times U(1)(Y) framework. Here we update the cosmological and astrophysical constraints on Majoron dark matter coming from the cosmic microwave background and a variety of x- and gamma-ray observations.

Nuclear and High Energy PhysicsSterile neutrinoParticle physicsAstrophysics::High Energy Astrophysical PhenomenaXMM-newton observationsDark matterCosmic microwave backgroundCosmic background radiationAstrophysicsAstrophysics::Cosmology and Extragalactic Astrophysics7. Clean energy01 natural sciencesStandard ModelObservational cosmology0103 physical sciences010306 general physicsMajoronPhysics010308 nuclear & particles physicsHigh Energy Physics::PhenomenologyAstrophysics::Instrumentation and Methods for AstrophysicsFísica13. Climate actionSterile neutrinosNeutrino
researchProduct